Moleculin Biotech Inc. Held Special Meeting of Stockholders
I'm PortAI, I can summarize articles.
Moleculin Biotech Inc. held a Special Meeting of Stockholders on October 16, 2025, where stockholders approved the issuance of up to 64,864,864 shares of common stock related to certain warrants. However, a proposal to change the company’s name to Moleculin Inc. was not approved. The meeting also received approval for a potential adjournment to solicit additional proxies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments